http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10e99b7efa86e4f2ea53c4e07477c491
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Ohtomo |
| name | Toshihiko Ohtomo |
| given-name | Toshihiko |
| organization-name | Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, Harvard Medical School; 2Dana-Farber Cancer Institute, Boston, Massachusetts; 3Swedish Cancer Institute, Seattle, Washington; 4University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 5Chugai Pharmaceutical Co. Ltd., Tokyo, Japan; and 6Karmanos Cancer Institute, Wayne State University, Detroit, Michigan From the Chugai Pharmaceutical Co Ltd, Fuji-Gotemba Research Laboratory, Shizuoka, Japan. Chugai Pharmaceutical Co., LTD., Tokyo, Japan Project Management Department Chugai Pharmaceutical Co. Tokyo Japan 5Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan; Safety Assessment Department Chugai Pharmaceutical Co. Ltd Tokyo Japan Chugai Pharmaceutical Co., Ltd., Tokyo, Japan |
Incoming Links
Total number of triples: 34.